Drug Shortage Report for AMINOPHYLLINE INJECTION USP
Report ID | 178367 |
Drug Identification Number | 00497193 |
Brand name | AMINOPHYLLINE INJECTION USP |
Common or Proper name | AMINOPHYLLINE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | AMINOPHYLLINE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25 X 10Ml amp |
ATC code | R03DA |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-31 |
Estimated end date | |
Actual end date | 2023-05-18 |
Shortage status | Resolved |
Updated date | 2023-05-19 |
Company comments | Product is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-05-19 | French | Compare |
v4 | 2023-05-19 | English | Compare |
v3 | 2023-02-01 | English | Compare |
v2 | 2022-12-14 | French | Compare |
v1 | 2022-12-14 | English | Compare |
Showing 1 to 5 of 5